Literature DB >> 32015464

Discovery of "heat shock metabolites" produced by thermotolerant actinomycetes in high-temperature culture.

Shun Saito1,2, Wataru Kato1, Hiroaki Ikeda1, Yohei Katsuyama2,3, Yasuo Ohnishi4,5, Masaya Imoto6.   

Abstract

In actinomycetes, many secondary metabolite biosynthetic genes are not expressed under typical laboratory culture conditions and various efforts have been made to activate these dormant genes. In this study, we focused on high-temperature culture. First, we examined the thermotolerance of 3160 actinomycete strains from our laboratory culture collection and selected 57 thermotolerant actinomycetes that grew well at 45 °C. These 57 thermotolerant actinomycetes were cultured for 5 days in liquid medium at both 30 °C and 45 °C. Culture broths were extracted with 1-butanol, and each extract was subjected to LC/MS analysis. The metabolic profiles of each strain were compared between the 30 °C and 45 °C cultures. We found that almost half of these thermotolerant actinomycetes produced secondary metabolites that were detected only in the 45 °C culture. This result suggests that high-temperature culture induces the production of dormant secondary metabolites. These compounds were named "heat shock metabolites (HSMs)." To examine HSM production in more detail, 18 strains were selected at random from the initial 57 strains and cultivated in six different media at 30 °C and 45 °C; as before, metabolic profiles of each strain in each medium were compared between the 30 °C and 45 °C cultures. From this analysis, we found a total of 131 HSMs. We identified several angucycline-related compounds as HSMs from two thermotolerant Streptomyces species. Furthermore, we discovered a new compound, murecholamide, as an HSM from thermotolerant Streptomyces sp. AY2. We propose that high-temperature culture of actinomycetes is a convenient method for activating dormant secondary metabolite biosynthetic genes.

Entities:  

Mesh:

Year:  2020        PMID: 32015464     DOI: 10.1038/s41429-020-0279-4

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  4 in total

Review 1.  Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture.

Authors:  Ji Hun Kim; Namil Lee; Soonkyu Hwang; Woori Kim; Yongjae Lee; Suhyung Cho; Bernhard O Palsson; Byung-Kwan Cho
Journal:  J Ind Microbiol Biotechnol       Date:  2021-06-04       Impact factor: 4.258

2.  Dihydromaniwamycin E, a Heat-Shock Metabolite from Thermotolerant Streptomyces sp. JA74, Exhibiting Antiviral Activity against Influenza and SARS-CoV-2 Viruses.

Authors:  Shun Saito; Kayo Funayama; Wataru Kato; Mayu Okuda; Meiko Kawamoto; Teruhiko Matsubara; Toshinori Sato; Akihiko Sato; Satoko Otsuguro; Michihito Sasaki; Yasuko Orba; Hirofumi Sawa; Katsumi Maenaka; Kazutoshi Shindo; Masaya Imoto; Midori A Arai
Journal:  J Nat Prod       Date:  2022-10-12       Impact factor: 4.803

Review 3.  Marine Actinomycetes, New Sources of Biotechnological Products.

Authors:  Sveta V Jagannathan; Erika M Manemann; Sarah E Rowe; Maiya C Callender; William Soto
Journal:  Mar Drugs       Date:  2021-06-25       Impact factor: 5.118

4.  Himalaquinones A-G, Angucyclinone-Derived Metabolites Produced by the Himalayan Isolate Streptomyces sp. PU-MM59.

Authors:  Yongyong Zhang; Mohsin T Cheema; Larissa V Ponomareva; Qing Ye; Tao Liu; Imran Sajid; Jürgen Rohr; Qing-Bai She; S Randal Voss; Jon S Thorson; Khaled A Shaaban
Journal:  J Nat Prod       Date:  2021-06-25       Impact factor: 4.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.